Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection.
about
Performance of [18F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of Alzheimer's disease.Negative 11C-PIB PET Predicts Lack of Alzheimer's Disease Pathology in Postmortem Examination.Infrequent false positive [18F]flutemetamol PET signal is resolved by combined histological assessment of neuritic and diffuse plaques.Amyloid pathology fingerprint differentiates post-traumatic stress disorder and traumatic brain injury.Estimation of amyloid distribution by [F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition
P2860
Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Post-mortem histopathology und ...... g flutemetamol F 18 injection.
@en
Post-mortem histopathology und ...... g flutemetamol F 18 injection.
@nl
type
label
Post-mortem histopathology und ...... g flutemetamol F 18 injection.
@en
Post-mortem histopathology und ...... g flutemetamol F 18 injection.
@nl
prefLabel
Post-mortem histopathology und ...... g flutemetamol F 18 injection.
@en
Post-mortem histopathology und ...... g flutemetamol F 18 injection.
@nl
P2093
P2860
P50
P1476
Post-mortem histopathology und ...... g flutemetamol F 18 injection.
@en
P2093
Adrian P L Smith
Aruna Chakrabarty
Azzam Ismail
Chester A Mathis
Chris J Buckley
Colin Smith
Gill Farrar
Kerstin Heurling
Michelle Zanette
Milos D Ikonomovic
P2860
P2888
P356
10.1186/S40478-016-0399-Z
P577
2016-12-12T00:00:00Z
P6179
1020424121